SSI Weekly Newsletter: Strategic Reviews, Merger Arbitrage, Tender Offers, and Portfolio Updates
Elevation Oncology (ELEV) is undergoing a strategic review after discontinuing its lead program, with potential 14–42% upside.
264 Views
SSI Weekly Highlights: Asset Sales, Liquidations, and Strategic Reviews in Focus for Key Companies
Wanda Hotel Development plans to sell its hotel management business, with proceeds potentially returned to shareholders, offering a 40%+ upside.
52 Views
Strategic Reviews, Company Sales, and Litigation: Analyzing Active Portfolio Ideas
Lifeway Foods is likely to be sold to Danone, with a potential 14%+ upside, following board changes. Sage Therapeutics rejected Biogen's offer...
659 Views
SSI Weekly Highlights: Tender Offers, Buyouts, Liquidations, and Strategic Acquisitions in Focus
Naturgy Energy Group plans a tender offer to repurchase 9% of shares at €26.50/share, with potential upside due to Spanish proration rules.
362 Views
Exploring Strategic Reviews: Key Opportunities in Biopharma and Food Sectors
Lifeway Foods (LWAY) faces a pending takeover by Danone, with a potential board overhaul and strategic acquisition synergies.
307 Views